1. Home
  2. BDSX

as 07-25-2024 2:30pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Precision Instruments

Nasdaq

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Founded: N/A Country:
United States
United States
Employees: N/A City: BOULDER
Market Cap: 175.5M IPO Year: 2020
Target Price: $3.15 AVG Volume (30 days): 160.5K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.54 EPS Growth: N/A
52 Week Low/High: $1.03 - $2.21 Next Earning Date: 08-05-2024
Revenue: $54,849,000 Revenue Growth: 34.70%
Revenue Growth (this year): 38.75% Revenue Growth (next year): 23.98%

BDSX Daily Stock ML Predictions

Stock Insider Trading Activity of Biodesix Inc. (BDSX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
O'Kane Kieran BDSX Chief Commercial Officer May 8 '24 Sell $1.48 468 $692.41 75,524 SEC Form 4
Hutton Scott BDSX President & CEO May 8 '24 Sell $1.48 3,764 $5,568.84 483,780 SEC Form 4
Vazquez Chris BDSX Chief Accounting Officer May 8 '24 Sell $1.48 244 $361.00 9,915 SEC Form 4
Pestano Gary Anthony BDSX Chief Development Officer May 8 '24 Sell $1.48 434 $642.10 124,248 SEC Form 4
Cowie Robin Harper BDSX CFO, Sec'y & Treasurer May 8 '24 Sell $1.48 980 $1,449.91 171,680 SEC Form 4
Vazquez Chris BDSX Chief Accounting Officer Feb 8 '24 Sell $1.92 1,077 $2,064.18 10,470 SEC Form 4
Vazquez Chris BDSX Chief Accounting Officer Feb 8 '24 Sell $1.66 922 $1,534.85 9,548 SEC Form 4
Pestano Gary Anthony BDSX Chief Development Officer Feb 8 '24 Sell $1.92 5,862 $11,235.11 128,272 SEC Form 4
Pestano Gary Anthony BDSX Chief Development Officer Feb 8 '24 Sell $1.66 5,022 $8,360.12 123,250 SEC Form 4
O'Kane Kieran BDSX Chief Commercial Officer Feb 8 '24 Sell $1.92 6,319 $12,111.00 73,417 SEC Form 4
O'Kane Kieran BDSX Chief Commercial Officer Feb 8 '24 Sell $1.66 5,412 $9,009.36 68,005 SEC Form 4
Cowie Robin Harper BDSX CFO, Sec'y & Treasurer Feb 8 '24 Sell $1.92 10,156 $19,464.99 178,109 SEC Form 4
Cowie Robin Harper BDSX CFO, Sec'y & Treasurer Feb 8 '24 Sell $1.66 8,699 $14,481.23 169,410 SEC Form 4
Hutton Scott BDSX President & CEO Feb 8 '24 Sell $1.92 34,682 $66,471.52 494,719 SEC Form 4
Hutton Scott BDSX President & CEO Feb 8 '24 Sell $1.66 29,708 $49,454.91 465,011 SEC Form 4

Share on Social Networks: